World Journal of Pharmacology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Homepage

Online Submission

Number of total visits: 296725

Number of visits today: 14

Number of downloads: 79051

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Leenhardt F, Gracia M, Perrin C, Muracciole-Bich C, Marion B, Roques C, Alexandre M, Firmin N, Pouderoux S, Mbatchi L, Gongora C, Jacot W, Evrard A. Liquid chromatography-tandem mass spectrometric assay for the quantification of CDK4/6 inhibitors in human plasma in a clinical context of drug-drug interaction. J Pharm Biomed Anal 2020;188:113438. [PMID: 32623316 DOI: 10.1016/j.jpba.2020.113438] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]

For:

Leenhardt F, Gracia M, Perrin C, Muracciole-Bich C, Marion B, Roques C, Alexandre M, Firmin N, Pouderoux S, Mbatchi L, Gongora C, Jacot W, Evrard A. Liquid chromatography-tandem mass spectrometric assay for the quantification of CDK4/6 inhibitors in human plasma in a clinical context of drug-drug interaction. J Pharm Biomed Anal 2020;188:113438. [PMID: 32623316 DOI: 10.1016/j.jpba.2020.113438] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]

Number	Citing Articles
1	Leenhardt F, Alexandre M, Guiu S, Pouderoux S, Beaujouin M, Lossaint G, Philibert L, Evrard A, Jacot W. Impact of pharmacist consultation at clinical trial inclusion: an effective way to reduce drug-drug interactions with oral targeted therapy. Cancer Chemother Pharmacol 2021;88:723-9. [PMID: 34286354 DOI: 10.1007/s00280-021-04331-0] [Reference Citation Analysis]
2	Leenhardt F, Fiteni F, Gauthier L, Alexandre M, Guiu S, Firmin N, Pouderoux S, Viala M, Lossaint G, Gautier C, Mollevi C, Gracia M, Gongora C, Mbatchi L, Evrard A, Jacot W. Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug–Drug Interactions Are the Usual Suspects. Pharmaceutics 2022;14:841. [DOI: 10.3390/pharmaceutics14040841] [Reference Citation Analysis]
3	Braal CL, Lam MH, Rienks T, van Tilborg CJ, Heuts W, Heijns JB, Bos MEMM, Mathijssen RHJ, de Bruijn P, Koolen SLW. Quantification of ribociclib in dried blood spots by LC-MS/MS: Method development and clinical validation. J Pharm Biomed Anal 2021;201:114118. [PMID: 34000578 DOI: 10.1016/j.jpba.2021.114118] [Reference Citation Analysis]
4	Llopis B, Robidou P, Tissot N, Pinna B, Gougis P, Aubart FC, Campedel L, Abbar B, Weil DR, Uzunov M, Gligorov J, Salem JE, Funck-Brentano C, Zahr N. Development and clinical validation of a simple and fast UPLC-ESI-MS/MS method for simultaneous quantification of nine kinase inhibitors and two antiandrogen drugs in human plasma: Interest for their therapeutic drug monitoring. J Pharm Biomed Anal 2021;197:113968. [PMID: 33618135 DOI: 10.1016/j.jpba.2021.113968] [Reference Citation Analysis]